Safety and Efficacy of HQP1351, a 3rd Generation Oral BCR-ABL Inhibitor in Patients with Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia: Preliminary Results of Phase I Study

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Jiang Qian; Huang Xiao Jun; Chen Zi; Men Lichuang; Liu Wei; Sun Xuemei; Ji Jiao; Wang Hengbang; Hou Yue; Hu Po; Zou Lei; Yan Hua; Huang Yingjie; Yang Dajun; Zhai Yifan;

  展开▼
• 作者单位

  Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

  Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Shanghai Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  Peking Univ Inst Hematol Peoples Hosp Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  Ascentage Pharma Grp Inc Rockville MD USA;

  HealthQuest Pharma Inc Guangzhou Guangdong Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词